Andy Corley

Yelroc Consulting Inc.

Co-founded eyeonics, Inc ◦ Developed new category of intraocular lens, the

accommodating IOL, known as Crystalens

◦ Sold to Bausch + Lomb in 2008, served as President of the Surgical Division

Co-founder of Chiron Ophthalmics ◦ General Manager of the Refractive Surgery Division

◦ Played a key role in the introduction of LASIK

2005 Orange County Entrepreneur of the Year

Crystalens 2005 AeA Technology of the Year

Graduate of Georgia Southern University

Owner, Yelroc Consulting Inc.

Senior Consultant to Bausch + Lomb ◦ Was Chairman of the Board of Technolas Perfect Vision,

recently purchased by B+L

Executive Chairman of NeoVista Inc.

Venture Partner at One Focus Ventures

Advisory boards: ◦ UCI School of Biomedical Engineering

◦ Scripps Genomic Institute

[ 4 ] CONFIDENTIAL

The Only Global Company Focused

Solely On Eye Health

[ 5 ]

Rich Heritage

1853

John Jacob

Bausch opens an

optical goods shop

in Rochester, N.Y.

Microscope,

binocular and

telescope

production begins

1893

Ray-Ban

sunglass

line

introduced

Manufactures world’s

first approved

soft contact lens

Acquire Dr. Mann

Pharma and

Pharmafair, Inc. to

form pharma business

segment

Develop

PureVision

SiHy

contact lens

2008

Lotemax

ophthalmic

steroid

launched

1870 –

1900 1910s 1930s 1970s 1980s 1990s

First optical quality

glass produced in

America

ReNu all-in-one

contact lens

cleaning solution

introduced

2000s

Divest

refractive

surgery

business thru

formation of

joint venture

with 2010

Perfect Vision

Besivance

antbacterial

launched

Acquisitions of

Groupe Chauvin,

CT Freda,

eyeonics and

Tubilux expand

pharma and

surgical portfolios

PureVision2HD

contact lenses

launched

Establish

present

business model

via

acquisition of

surgical

product lines

and divestiture

of sunglass and

other non-core

business lines

Crystalens AO

launched for

cataract

patients

BioTrue

multipurpose

solution

launched

[ 6 ]

Global Reach and Perspective

Revenues in

100+ Countries ~11,000 Global

Employees

Manufacturing

in 9 Countries

6 Major Global

D&R Sites

[ 7 ]

Aging

population 65+ age group (~630 MM) expected to double by 2030 (~1.2 Bn)1

Type 2

Diabetes Number of cases doubled over last 30 years2; increasing prevalence

Expanding

Middle Class Increasing demand & willingness to pay for eye health services

Heightened

innovation Comfort, safety and efficacy enhanced through technology

Emerging

markets Contributing up to ~50% of global GDP growth through the decade3

Eye health is resilient to economic and legislative factors

Key Macro Trends Fueling Demand for Eye Health Services

1 Source: United Nations Population Division World Population Prospects, 2010 Revision 2 Source: USA Today, “Diabetes on the Upswing”, 6/25/2011 3 Source: World Market Monitor

[ 8 ]

Solely Focused on Eye Health

Geographic Expansion

Focus on Execution

Internal and External Pipeline Growth

Brand and Scale

PHARMA VISION

CARE

SURGICAL

Customers+ Patients

[ 9 ]

Broad Product Portfolio

Surgical Pharmaceutical Vision Care

Multipurpose Solutions

Contact Lenses

Cosmetic Contact Lenses

Ocular Vitamin

Antibiotic

Dry Eye Antiviral

Anti-inflammatory

Intraocular Lenses (IOLs)

Surgical Equipment

[ 10 ]

Surgical Serving the Needs of Ophthalmic Surgeons Worldwide

Refractive

Retinal

Cataract

[ 11 ]

Cataract Surgery

Most Commonly Performed Surgery in the World

Surgical Equipment Intraocular Lenses (IOLs) Surgical Instruments/Packs

Akreos® IOLs

Viscoelastics

[ 12 ]

Retinal Surgery

Treating eye problems of the

retina, macula, and vitreous fluid

Surgical Equipment Surgical Instruments

[ 13 ]

Refractive Surgery

Performed to decrease or

eliminate dependency on glasses or contact lenses

Surgical Equipment Surgical Instruments

TECHNOLAS® Excimer Workstation

ZYOPTIX® Diagnostic Workstation